Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alport Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03749447
What this trial is testing

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

Who this might be right for
Chronic Kidney DiseasesAlport SyndromeAutosomal Dominant Polycystic Kidney
Biogen 270
Not applicableStudy completedNCT01705132
What this trial is testing

Urinary Biomarkers of the Progression of Alport Kidney Disease

Who this might be right for
Alport Syndrome
University of Minnesota 80
Post-approval studies (Phase 4)UnknownNCT05655728
What this trial is testing

Treatment With Metformin in Chinese Children With Alport Syndrome

Who this might be right for
Alport SyndromeMetformin
Peking University First Hospital 78
Testing effectiveness (Phase 2)Study completedNCT04937907
What this trial is testing

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

Who this might be right for
Alport Syndrome, X-Linked
Shanghai Children's Hospital 50
Post-approval studies (Phase 4)Study completedNCT06499948
What this trial is testing

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseAlport Nephropathy
Stefan Lujinschi 12
Not applicableLooking for participantsNCT02378805
What this trial is testing

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Who this might be right for
Alport SyndromeHereditary Kidney DiseasePediatric Kidney Disease+2 more
University Hospital Goettingen 800
Not applicableStudy completedNCT00622544
What this trial is testing

A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome

Who this might be right for
Alport SyndromeKidney Disease
University of Minnesota 44
Testing effectiveness (Phase 2)Looking for participantsNCT07523581
What this trial is testing

EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety

Who this might be right for
Alport Syndrome, X-LinkedAlport Syndrome, Autosomal Recessive
Eloxx Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT06425055
What this trial is testing

Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)

Who this might be right for
Alport Syndrome
Enyo Pharma 26
Not applicableStudy completedNCT01696253
What this trial is testing

Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study

Who this might be right for
Alport Syndrome
University of Minnesota 360
Not applicableNot Yet RecruitingNCT05133050
What this trial is testing

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

Who this might be right for
Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 510
Not applicableLooking for participantsNCT04947813
What this trial is testing

Genotype-Phenotype Correlations in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 8,165
Large-scale testing (Phase 3)Study completedNCT01485978
What this trial is testing

Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

Who this might be right for
Renal Insufficiency, Chronic
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920
What this trial is testing

Atrasentan in Patients With Proteinuric Glomerular Diseases

Who this might be right for
IgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more
Novartis Pharmaceuticals 103
Not applicableEnded earlyNCT02718027
What this trial is testing

Biomarker for Alport Syndrome (BioAlport)

Who this might be right for
Nephritis, HereditaryHematuria-Nephropathy-Deafness Syndrome
CENTOGENE GmbH Rostock 12
Testing effectiveness (Phase 2)Study completedNCT05448755
What this trial is testing

ELX-02 in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Eloxx Pharmaceuticals, Inc. 3
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Large-scale testing (Phase 3)Looking for participantsNCT05944016
What this trial is testing

Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Who this might be right for
Chronic Kidney Failure in Children and Young Adults
University Hospital Goettingen 102
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000